Search

Search Constraints

You searched for: Author/Creator Boudewijns, Steve

Search Results

1. Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients. (2nd July 2016)

3. Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients. Issue 6 (July 2016)

4. Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients. (1st January 2022)

5. Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination. (2nd August 2016)

6. Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition. Issue 1 (December 2016)

7. Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination. (1st January 2020)